Target intelligence / Profile preview

Immediate early protein 2 (HCMV) (IE2)

Target
IE2
Molecular classification
Other (part of viral transcription factors), Transcription factor
01

Overview

IE2-exon5 refers to the fifth exon within the human cytomegalovirus UL122 gene, which encodes part of the immediate early protein 2 (IE2) family, including isoforms such as IE2-86, IE2-60, and IE2-40[2][9]. This region is necessary for the production of key viral transcription factors that regulate the initiation of viral and selected host gene transcription during acute infection[2][7]. Proteins containing this exon are essential for efficient viral replication, particularly in the late phase, and play key roles in both activation and repression of viral gene expression[7][2]. However, "IE2-exon5" is not a standard molecular target term; its use is primarily for research on the function of specific domains in viral gene expression and immune recognition[1].

Other names
UL122 exon 5IE2 exon 5IE2-86IE2-60IE2-40
02

Mechanism of action

Not applicable; the region is not a recognized drug target distinct from the parent protein.

03

Biological functions

Regulation of viral gene transcriptionTransactivation/repression of viral promotersControl of viral replication/late gene expression
04

Disease associations

Infection (human cytomegalovirus)important for viral replication and pathogenesis

Beyond the preview

Go deeper on Immediate early protein 2 (HCMV) (IE2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immediate early protein 2 (HCMV) (IE2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call